Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
This study is looking at ways to reduce bleeding after heart surgery (cardiac surgery) that uses a heart-lung machine (cardiopulmonary bypass). It compares two approaches: receiving your own fresh whole blood (Fresh Autologous whole Blood) collected before surgery, or the usual care for bleeding, which might include transfusions of banked blood products. The study aims to see if using your own fresh blood can reduce the amount of blood lost within 24 hours after surgery. You could join if you are between 18 and 90 years old, are having elective cardiac surgery with cardiopulmonary bypass, and are willing to receive blood transfusions. The study is currently unclear about its recruitment status.
- Study design
- This is a randomized interventional trial with 70 planned participants, comparing two treatment groups.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Blood loss will be measured within 24 hours after surgery.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Nathan Clendenen, M.D. · PRINCIPAL_INVESTIGATOR · University of Colorado - School of Medicine
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Estimated Blood LossWithin 24 hours after surgery
Blood loss is estimated as a percent of total estimated blood volume in the first 24 hours after cardiac surgery.